Thrivent Financial for Lutherans’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-987,450
Closed -$40.5M 2467
2023
Q2
$40.5M Buy
987,450
+54,910
+6% +$2.25M 0.09% 275
2023
Q1
$33.3M Buy
932,540
+13,208
+1% +$472K 0.08% 295
2022
Q4
$34.7M Buy
919,332
+10,853
+1% +$410K 0.09% 282
2022
Q3
$40.2M Sell
908,479
-368,304
-29% -$16.3M 0.11% 228
2022
Q2
$47.3M Sell
1,276,783
-284,730
-18% -$10.5M 0.13% 209
2022
Q1
$57.8M Buy
1,561,513
+27,514
+2% +$1.02M 0.11% 223
2021
Q4
$46.7M Buy
1,533,999
+146,235
+11% +$4.45M 0.09% 263
2021
Q3
$46.5M Buy
1,387,764
+1,264,397
+1,025% +$42.4M 0.09% 253
2021
Q2
$4.92M Buy
123,367
+2,054
+2% +$81.9K 0.01% 927
2021
Q1
$5.45M Buy
+121,313
New +$5.45M 0.01% 877
2017
Q4
Sell
-500
Closed -$25K 2164
2017
Q3
$25K Buy
+500
New +$25K ﹤0.01% 2061
2014
Q2
Sell
-150,200
Closed -$6.49M 1722
2014
Q1
$6.49M Buy
+150,200
New +$6.49M 0.04% 389